These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 92774)
1. Influence of cholinergic agents on dopamine release from medial basal hypothalamus. Perkins NA; Westfall TC Neurosci Lett; 1979 Mar; 11(3):283-7. PubMed ID: 92774 [TBL] [Abstract][Full Text] [Related]
2. Presynaptic M2-muscarinic receptors on noradrenergic nerve endings and endothelium-derived M3 receptors in cat cerebral arteries. Alonso MJ; Arribas S; Marín J; Balfagón G; Salaices M Brain Res; 1991 Dec; 567(1):76-82. PubMed ID: 1726141 [TBL] [Abstract][Full Text] [Related]
3. Effect of specific M1, M2 muscarinic receptor agonists on REM sleep generation. Velazquez-Moctezuma J; Gillin JC; Shiromani PJ Brain Res; 1989 Nov; 503(1):128-31. PubMed ID: 2482113 [TBL] [Abstract][Full Text] [Related]
4. Cholinergic action in the nucleus accumbens: modulation of dopamine and acetylcholine release. de Belleroche JS; Gardiner IM Br J Pharmacol; 1982 Feb; 75(2):359-65. PubMed ID: 7186823 [TBL] [Abstract][Full Text] [Related]
5. Muscarinic receptor subtypes mediating the mucosal response to neural stimulation of guinea pig ileum. Carey HV; Tien XY; Wallace LJ; Cooke HJ Am J Physiol; 1987 Sep; 253(3 Pt 1):G323-9. PubMed ID: 2443017 [TBL] [Abstract][Full Text] [Related]
6. Acetylcholine stimulation of the sympathetic ganglia: effects of taurine and nicotinic and muscarinic ganglion block. Hilton JG J Pharmacol Exp Ther; 1977 Nov; 203(2):426-34. PubMed ID: 71348 [No Abstract] [Full Text] [Related]
7. Modulation of dopamine release from neuron-enriched tissue cultures by cholinergic agents. Barochovsky O; Bradford HF J Neurochem; 1987 Mar; 48(3):798-803. PubMed ID: 3806105 [TBL] [Abstract][Full Text] [Related]
8. Intracellular calcium release in N1E-115 neuroblastoma cells is mediated by the M1 muscarinic receptor subtype and is antagonized by McN-A-343. Mathes C; Wang SS; Vargas HM; Thompson SH Brain Res; 1992 Jul; 585(1-2):307-10. PubMed ID: 1380873 [TBL] [Abstract][Full Text] [Related]
9. Pathways involved in muscarinic M1 and M2 receptor stimulation in rabbit vas deferens. Eltze M Eur J Pharmacol; 1994 Sep; 263(1-2):31-7. PubMed ID: 7529712 [TBL] [Abstract][Full Text] [Related]
10. Effects of cholinergic agonists and antagonists on interleukin-2-induced corticotropin-releasing hormone release from the mediobasal hypothalamus. Karanth S; Lyson K; McCann SM Neuroimmunomodulation; 1999; 6(3):168-74. PubMed ID: 10213914 [TBL] [Abstract][Full Text] [Related]
11. Production of decremental oscillations following spike potential by muscarinic drugs, histamine and bradykinin in cat sympathetic ganglion. Machová J; Boska D Neuropharmacology; 1979 Apr; 18(4):355-60. PubMed ID: 88022 [No Abstract] [Full Text] [Related]
12. Effect of extracellular calcium concentration on potency of muscarinic agonists at M1 and M2 receptors in rabbit vas deferens. Dörje F; Rettenmayr NM; Mutschler E; Lambrecht G Eur J Pharmacol; 1991 Oct; 203(3):417-20. PubMed ID: 1723047 [TBL] [Abstract][Full Text] [Related]
13. Halothane and isoflurane differentially affect the regulation of dopamine and gamma-aminobutyric acid release mediated by presynaptic acetylcholine receptors in the rat striatum. Salord F; Keita H; Lecharny JB; Henzel D; Desmonts JM; Mantz J Anesthesiology; 1997 Mar; 86(3):632-41. PubMed ID: 9066330 [TBL] [Abstract][Full Text] [Related]
14. Effects of several muscarinic agonists on cardiac performance and the release of noradrenaline from sympathetic nerves of the perfused rabbit heart. Fozard JR; Muscholl E Br J Pharmacol; 1972 Aug; 45(4):616-29. PubMed ID: 5085235 [TBL] [Abstract][Full Text] [Related]